Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1680KRW
−16.03 BKRW
794.71 BKRW
2.10 M
About JEIL PHARMA HOLDINGS INC.
Sector
CEO
Sang-Cheol Han
Headquarters
Seoul
Founded
1959
ISIN
KR7002620003
FIGI
BBG000BGY469
Jeil Pharma Holdings, Inc. engages in the provision of management consulting, leasing, and investment services. The company was founded on March 7, 1959 and is headquartered in Seoul, South Korea.
Frequently Asked Questions
The current price of 002620 is 9810 KRW — it has decreased by 0.10% in the past 24 hours. Watch JEIL PHARMA HOLDINGS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JEIL PHARMA HOLDINGS INC. stocks are traded under the ticker 002620.
002620 stock has fallen by 0.71% compared to the previous week, the month change is a 2.97% fall, over the last year JEIL PHARMA HOLDINGS INC. has showed a 23.66% decrease.
002620 reached its all-time high on Jun 15, 2016 with the price of 139000 KRW, and its all-time low was 2090 KRW and was reached on May 25, 2004. View more price dynamics on 002620 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002620 stock is 12.37% volatile and has beta coefficient of 0.31. Track JEIL PHARMA HOLDINGS INC. stock price on the chart and check out the list of the most volatile stocks — is JEIL PHARMA HOLDINGS INC. there?
Today JEIL PHARMA HOLDINGS INC. has the market capitalization of 150.90 B, it has decreased by 3.16% over the last week.
Yes, you can track JEIL PHARMA HOLDINGS INC. financials in yearly and quarterly reports right on TradingView.
JEIL PHARMA HOLDINGS INC. is going to release the next earnings report on Aug 9, 2024. Keep track of upcoming events with our Earnings Calendar.
002620 net income for the last quarter is 44.42 M KRW, while the quarter before that showed −26.84 B KRW of net income which accounts for 100.17% change. Track more JEIL PHARMA HOLDINGS INC. financial stats to get the full picture.
Yes, 002620 dividends are paid annually. The last dividend per share was 50.00 KRW. As of today, Dividend Yield (TTM)% is 0.51%. Tracking JEIL PHARMA HOLDINGS INC. dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JEIL PHARMA HOLDINGS INC. EBITDA is 5.97 B KRW, and current EBITDA margin is 3.04%. See more stats in JEIL PHARMA HOLDINGS INC. financial statements.
Like other stocks, 002620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JEIL PHARMA HOLDINGS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JEIL PHARMA HOLDINGS INC. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JEIL PHARMA HOLDINGS INC. stock shows the sell signal. See more of JEIL PHARMA HOLDINGS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.